US
Actelion to appeal damages order
<p>Swiss biotechnology group Actelion said Wednesday that it would appeal against $547 million in damages awarded by a California court to Japanese company Asahi Kasei Pharma.</p>
<p>Swiss biotechnology group Actelion said Wednesday that it would appeal against $547 million in damages awarded by a California court to Japanese company Asahi Kasei Pharma.</p>
